Insider screener

Period: 12 months + Add filter
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

59,646 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

59,646 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

59,646 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

59,646 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
59,646 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
59,646 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

59,646 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
Craig E Hunsaker EVP, People & Culture
Sold on a plan
$549.54K 37,358 at 14.71
3.1%
Planned (10b5-1)
3 Feb 2026
Gary W Staley SVP Global Sales NSE
Sold at will
$537.63K 20,742 at 25.92
10.2%
Not planned
3 Feb 2026
David J. Volk Director
Bought
$503.28K 27,000 at 18.64
×23
First buy on file
3 Feb 2026
William Lewis Chair and CEO
Sold at will
$470.43K 3,009 at 156.34
1.0%
Not planned
3 Feb 2026
Pierre Naude Director
Sold at will
$453.47K 24,273 at 18.68
2.0%
Not planned
3 Feb 2026
Balu Balakrishnan Director · indirect
Sold at will 2×
$451.11K 10,080 at 44.75
1.7%
Not planned
3 Feb 2026
William E. Rote Chief Research Officer
Sold on a plan
$409.10K 12,446 at 32.87
10.2%
Planned (10b5-1)
3 Feb 2026
Jack Bendheim President and CEO · indirect
Sold on a plan 2×
$400.61K 9,660 at 41.47
30.2%
Planned (10b5-1)
3 Feb 2026
Michael S Williams Chief Executive Officer
Sold on a plan
$399.93K 19,017 at 21.03
2.7%
Planned (10b5-1)
3 Feb 2026
Kimberly Anne Kellermann SVP, Chief Operations Officer
Sold at will
$379.03K 5,265 at 71.99
47.5%
Not planned
3 Feb 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$378.23K 1,639 at 230.77
1.2%
Planned (10b5-1)
3 Feb 2026
Barbara Weber Director, Executive Chair
Sold at will 2×
$374.29K 30,519 at 12.26
1.8%
Not planned
3 Feb 2026
James P Williams SVP-CHRO
Sold at will
$352.17K 5,243 at 67.17
9.7%
Not planned
3 Feb 2026
Jacques Tapiero Director
Sold at will
$319.25K 5,000 at 63.85
13.7%
Not planned
3 Feb 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
3 Feb 2026
Sean Desmond CEO & President
Sold at will
$299.79K 16,047 at 18.68
2.6%
Not planned
3 Feb 2026
Mary Clara Capel Retired Board Member
Sold at will
$296.55K 5,000 at 59.31
19.7%
Not planned
3 Feb 2026
Teresa D. Bos 10% owner
Sold at will
$296.21K 20,889 at 14.18
1.9%
Not planned
3 Feb 2026
Brian K Chaney Senior Vice President
Sold at will
$288.04K 11,157 at 25.82
11.2%
Not planned
3 Feb 2026
Robert Fauber President and CEO
Sold on a plan
$286.87K 575 at 498.90
0.9%
Planned (10b5-1)
3 Feb 2026
Sold at will
$261.23K 7,500 at 34.83
0.7%
Not planned
3 Feb 2026
Sally A Steele Director
Sold at will
$256.48K 4,000 at 64.12
9.1%
Not planned
3 Feb 2026
Peter D Fitzsimmons President and CEO
Bought
$251.02K 13,350 at 18.80
15.5%
First buy on file
3 Feb 2026
Riccardo Procacci Senior Vice President
Sold at will
$248.09K 800 at 310.11
4.8%
Not planned
3 Feb 2026
Asuka Nakahara Director
Sold at will
$245.77K 8,275 at 29.70
12.5%
Not planned
3 Feb 2026
Anthony Folger Chief Financial Officer
Sold on a plan 2×
$240.01K 6,000 at 40.00
10.9%
Planned (10b5-1)
3 Feb 2026
Peter Heerma Chief Commercial Officer
Sold at will
$234.80K 7,310 at 32.12
5.3%
Not planned
3 Feb 2026
Emily M. Leproust Chief Executive Officer
Sold at will
$232.93K 5,001 at 46.58
0.6%
Not planned
3 Feb 2026
Christopher R. Cline Chief Financial Officer
Sold at will
$232.61K 7,242 at 32.12
6.0%
Not planned
3 Feb 2026
Elizabeth E Reed Chief Legal Officer and GC
Sold at will
$230.46K 7,175 at 32.12
6.2%
Not planned
3 Feb 2026
Adam Crystal President, R&D
Sold at will 2×
$226.30K 18,452 at 12.26
9.0%
Not planned
3 Feb 2026
Kenneth M Walsh Director
Sold at will
$224.72K 10,000 at 22.47
9.8%
Not planned
3 Feb 2026
Jula Inrig Chief Medical Officer
Sold at will
$223.43K 6,956 at 32.12
6.1%
Not planned
3 Feb 2026
David R Duncan Director · indirect
Sold at will 3×
$220.51K 8,626 at 25.56
100%
Sold half or more
3 Feb 2026
Kirk W Walters Director
Sold at will
$206.68K 909 at 227.37
13.2%
Not planned
3 Feb 2026
Gregory Orenstein CFO & Treasurer
Sold at will
$197.32K 10,562 at 18.68
2.3%
Not planned
3 Feb 2026
Bought 2×
$191.23K 413 at 463.01
2.7%
First buy on file
3 Feb 2026
Bala Sathyanarayanan EVP, Chief Human Resources Off
Sold at will
$180.65K 2,499 at 72.29
5.0%
Not planned
3 Feb 2026
Eric Richard Remer Chief Executive Officer
Sold on a plan 2×
$178.87K 16,403 at 10.90
0.6%
Planned (10b5-1)
3 Feb 2026
Ritadhwaja Jebens Singh EVP & Chief Digital Officer
Sold on a plan
$178.22K 5,880 at 30.31
5.4%
Planned (10b5-1)
3 Feb 2026
Gary Yu President and CEO
Sold at will
$176.47K 2,900 at 60.85
2.5%
Not planned
3 Feb 2026
Jay D. Richards Officer of Subsidiary
Sold at will
$174.70K 3,506 at 49.83
8.9%
Not planned
3 Feb 2026
Justin Takao Treasurer, CAO & CFO
Sold at will 3×
$173.47K 14,807 at 11.72
69.6%
Sold half or more
3 Feb 2026
Sold at will
$156.31K 11,000 at 14.21
64.0%
Sold half or more
3 Feb 2026
Harlan S Robins Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
3 Feb 2026
April Rieger Chief Lgl. & Admin Ofc., Sec
Sold at will
$150.91K 8,078 at 18.68
3.5%
Not planned
3 Feb 2026
James J Claussen Executive Vice President & CFO
Sold on a plan
$149.16K 4,972 at 30.00
6.3%
Planned (10b5-1)
3 Feb 2026
Erika Ashley Fisher Chief Legal Officer
Sold on a plan
$148.36K 589 at 251.88
5.1%
Planned (10b5-1)
3 Feb 2026
Jason Drew Smith General Counsel
Sold at will 3×
$147.26K 7,479 at 19.69
12.7%
Not planned
3 Feb 2026
Mark Schoenberg Chief Medical Officer
Sold at will 3×
$145.17K 7,373 at 19.69
4.8%
Not planned
Showing 45,251–45,300 of 59,646. ← Newer Page 906 of 1,193 Older →